Half-life (h) | β-1 Receptor selectivity | Lipophilic/ hydrophilic | Intrinsic sympathomimetic activity | Peripheral vasodilation | Usual dose range (mg/days) | Daily cost at lower and upper end of usual dosing (SGD) | |
---|---|---|---|---|---|---|---|
First generation | |||||||
Propranolol | 3–4 | 0 | High | Yes | No | 40–180 | 0.11–0.66 |
Second generation | |||||||
Atenolol | 6–9 | + | Low | No | No | 25–100 | 0.06–0.11 |
Bisoprolol | 9–12 | ++ | Moderate | No | No | 5–20 | 0.28–1.12 |
Metoprolol (tartrate) | 3–4 | ++ | High | No | No | 100–400 | 0.36–0.52 |
Third generation | |||||||
Carvedilol | 7–10 | 0 | Moderate | No | Yes | 12.5–50 | 0.68–0.92 |
Labetalol | 3–4 | + | Low | Yes | Yes | 200–800 | 0.50–2.00 |
Nebivolol | 8–27 | +++ | Moderate | No | Yes | 5–10 | 0.98–1.96 |
Adapted from Feldman et al3 and Koda-Kimble and Young's Applied Therapeutics 10th edn, 2012.4 SGD, Singapore dollars.